IFP Advisors’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-100
Closed -$235 – 5044
2025
Q4
$235 Hold
100
– – ﹤0.01% 4450
2025
Q3
$306 Sell
100
-1,421
-93% -$4.06K ﹤0.01% 4297
2025
Q2
$4.81K Buy
1,521
+670
+79% +$2.2K ﹤0.01% 3418
2025
Q1
$3.13K Buy
851
+761
+846% +$3.06K ﹤0.01% 2999
2024
Q4
$347 Sell
90
-10
-10% -$36 ﹤0.01% 3519
2024
Q3
$282 Hold
100
– – ﹤0.01% 3189
2024
Q2
$123 Hold
100
– – ﹤0.01% 3163
2024
Q1
$79 Hold
100
– – ﹤0.01% 3071
2023
Q4
$95 Hold
100
– – ﹤0.01% 2974
2023
Q3
$108 Hold
100
– – ﹤0.01% 3218
2023
Q2
$90 Hold
100
– – ﹤0.01% 3358
2023
Q1
$1.59K Hold
100
– – ﹤0.01% 2967
2022
Q4
$2K Sell
100
-2,000
-95% -$2.67K ﹤0.01% 4125
2022
Q3
$34K Buy
2,100
+2,000
+2,000% +$5.24K ﹤0.01% 2661
2022
Q2
$2K Hold
100
– – ﹤0.01% 4094
2022
Q1
$2K Hold
100
– – ﹤0.01% 4094
2021
Q4
$1K Sell
100
-10
-9% -$61 ﹤0.01% 2961
2021
Q3
$2K Buy
110
+100
+1,000% +$856 ﹤0.01% 2826
2021
Q2
$0 Sell
10
-4,300
-100% -$42.2K ﹤0.01% 3087
2021
Q1
$33K Buy
+4,310
New +$48.6K ﹤0.01% 1615

Other funds holding CLOV

IFP Advisors's CLOV Position: Q1 2026 in Review

IFP Advisors sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 100 shares — an estimated $235 sold.

IFP Advisors first reported a position in CLOV in Q1 2021 and held it in 20 quarters. The position peaked at $34K in Q3 2022. 209 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • IFP Advisors reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
  • IFP Advisors sold 100 Clover Health Investments shares in Q1 2026, an estimated $235.
  • IFP Advisors first reported a position in Clover Health Investments in Q1 2021 and held it in 20 quarters.
  • IFP Advisors's Clover Health Investments position peaked at $34K in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.